Farallon Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341M | Buy |
7,900,000
+2,169,000
| +38% | +$93.7M | 1.47% | 26 |
|
|
2025
Q1 | $198M | Buy |
5,731,000
+1,536,000
| +37% | +$53.1M | 0.98% | 33 |
|
|
2024
Q4 | $115M | Buy |
4,195,000
+2,448,000
| +140% | +$67.2M | 0.51% | 46 |
|
|
2024
Q3 | $44.5M | Buy |
+1,747,000
| New | +$44.5M | 0.2% | 63 |
|
|
2024
Q1 | – | Sell |
-6,000
| Closed | -$242K | – | 172 |
|
|
2023
Q4 | $242K | Buy |
+6,000
| New | +$242K | ﹤0.01% | 118 |
|